Appropriate surgical procedures for Chiari type 1 malformation and associated syrinx based on radiological characteristics of the craniovertebral junction.


Journal

Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 27 03 2018
accepted: 15 01 2019
revised: 06 12 2018
pubmed: 27 1 2019
medline: 9 10 2020
entrez: 27 1 2019
Statut: ppublish

Résumé

Several surgical procedures can be applied for syrinx associated with Chiari type 1 malformation; however, it remains controversial as to which approach is the most effective. Here, we evaluated the indications and limitations of foramen magnum decompression (FMD) with or without dural plasty. Forty patients with Chiari type 1 malformation were surgically treated and followed up for > 12 months. Thirty-two patients (80.0%) underwent FMD with removal of only the outer dura mater layer, while eight patients underwent FMD with dural plasty. We evaluated surgery-related complications and preoperative radiological findings affecting syrinx shrinkage rates. Post-surgery, the mean syrinx shrinkage rates were 0.32 ± 0.44 in the outer layer-removal group and 0.72 ± 0.27 in the dural plasty group (P = 0.012). Surgery-related complications were less frequent, but reoperation was more frequent, in the outer layer-removal group. The extent of tonsillar descent significantly affected syrinx shrinkage in FMD with outer layer removal (P = 0.042). The outcomes of both approaches in patients with tonsillar descent < 10.0 mm were similar. The dura mater in the posterior fossa was thin, necessitating dural plasty with FMD, while the spinal dura was sufficiently thick for removal of the outer layer in the Chiari patients. These histological differences corresponded with the inferior margin of the cerebellar tonsil. Recognizing the appropriate surgical indication for achieving good post-procedural outcomes is necessary for reducing complications and improving outcomes of FMD for Chiari type 1 malformations.

Identifiants

pubmed: 30684108
doi: 10.1007/s10143-019-01079-3
pii: 10.1007/s10143-019-01079-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

575-580

Références

Acta Neurochir (Wien). 1993;123(3-4):157-9
pubmed: 8237495
Neurosurgery. 1995 Oct;37(4):673-8; discussion 678-9
pubmed: 8559295
Neurosurg Rev. 2017 Apr;40(2):213-221
pubmed: 27251046
J Neurosurg. 2003 Mar;98(3):459-64
pubmed: 12650414
J Neurosurg Spine. 2015 Dec;23(6):812-9
pubmed: 26315957
Acta Neurochir (Wien). 1998;140(8):745-54
pubmed: 9810440
Cleve Clin Q. 1958 Jan;25(1):4-8
pubmed: 13500572
Neuropathology. 2000 Mar;20(1):38-43
pubmed: 10935435
Neurosurg Focus. 2001 Jul 15;11(1):E2
pubmed: 16724812
J Neurosurg. 1998 Jun;88(6):962-8
pubmed: 9609289
Clin Neurol Neurosurg. 2000 Jun;102(2):91-6
pubmed: 10817895
Acta Neurochir (Wien). 2002 Jul;144(7):649-64
pubmed: 12181698
J Neurosurg. 2018 Jan;128(1):165-173
pubmed: 28409726
Neurosurgery. 1993 Nov;33(5):845-9; discussion 849-50
pubmed: 8264881
Spine (Phila Pa 1976). 1995 Dec 1;20(23):2484-6
pubmed: 8610241
J Neurosurg. 1994 Jan;80(1):3-15
pubmed: 8271018
Neurosurgery. 1992 Aug;31(2):231-44; discussion 244-5
pubmed: 1513429

Auteurs

Kiyoshi Ito (K)

Department of Neurosurgery, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan. kitoh@shinshu-u.ac.jp.

Mitsunori Yamada (M)

Division of Neuropathology, Department of Brain Disease Research, Center for Clinical Research, Shinshu University School of Medicine, Matsumoto, Japan.

Tetsuyoshi Horiuchi (T)

Department of Neurosurgery, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.

Kazuhiro Hongo (K)

Department of Neurosurgery, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH